Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:40:43.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:43:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:52:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. This prevents viewing the NCT03554473 study details and related navigation on ClinicalTrials.gov.
    Difference
    25%
    Check dated 2026-09-23T00:46:01.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a maintenance release of the page. This change seems to affect the underlying platform or user interface rather than the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:01:56.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The study page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be an administrative update to the record that does not change the study content.
    Difference
    0.0%
    Check dated 2026-09-01T20:38:44.000Z thumbnail image

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.